Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Agilon Health (AGL) Accumulated Depreciation & Amortization (2020 - 2025)

Agilon Health (AGL) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with $28.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 16.89% year-over-year to $28.6 million, compared with a TTM value of $28.6 million through Dec 2025, up 16.89%, and an annual FY2025 reading of $28.6 million, up 16.89% over the prior year.
  • Accumulated Depreciation & Amortization was $28.6 million for Q4 2025 at Agilon Health, up from $24.5 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $28.6 million in Q4 2025 and bottomed at $13.8 million in Q4 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $20.3 million, with a median of $20.2 million recorded in 2023.
  • The sharpest move saw Accumulated Depreciation & Amortization skyrocketed 101.65% in 2021, then decreased 6.12% in 2022.
  • Year by year, Accumulated Depreciation & Amortization stood at $14.7 million in 2021, then dropped by 6.12% to $13.8 million in 2022, then skyrocketed by 46.39% to $20.2 million in 2023, then rose by 21.34% to $24.5 million in 2024, then increased by 16.89% to $28.6 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for AGL at $28.6 million in Q4 2025, $24.5 million in Q4 2024, and $20.2 million in Q4 2023.